Study

54 patients with SIBO and IBS received S.Boulardii.

By OxidativeState · · 1 min read

PubMed: Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study

54 patients with SIBO and IBS received S.Boulardii.
The results?
-less diarrhea
-improved digestive symptoms
-reduced bacterial overgrowth

CNCM I-745 strand is effective in treating SIBO.

The study

  1. Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot StudyDig Dis · 2023 · PMID 36630947
Read on X ↗

Get the next article in your inbox

Join the free newsletter. Science-backed health, no spam.